MedPath

The effects of synbiotic supplement containing Bacillus coagulans on women with polycystic ovarian syndrome.

Phase 3
Recruiting
Conditions
Polycystic Ovarian Syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20150815023617N6
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

Having polycystic ovary syndrome according to Rotterdam criteria
At least 2 weeks after the diagnosis and treatment of PCOS
Being in the age range of 18-45 years
Being in the BMI range: 18.5-35
Willingness to cooperate

Exclusion Criteria

Being pregnant
Having liver disease, Kidney failure and heart failure, Infectious or inflammatory diseases, Thyroid disorders, Diabetes, Cancers, Hyperprolactinemia
Take supplements or products containing synbiotics or probiotics in the past month
Taking antibiotics in the last three months
Consumption of corticosteroids or omega-3

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath